Nuveen LLC Buys Shares of 42,770 Waldencast PLC $WALD

Nuveen LLC bought a new stake in shares of Waldencast PLC (NASDAQ:WALD) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 42,770 shares of the company’s stock, valued at approximately $128,000.

Several other hedge funds and other institutional investors have also bought and sold shares of WALD. Stonebrook Private Inc. bought a new position in Waldencast during the 4th quarter valued at about $48,000. Ethic Inc. bought a new position in Waldencast during the 4th quarter valued at about $56,000. Wells Fargo & Company MN lifted its stake in shares of Waldencast by 29.9% in the 4th quarter. Wells Fargo & Company MN now owns 14,571 shares of the company’s stock worth $59,000 after purchasing an additional 3,358 shares during the period. Barclays PLC lifted its stake in shares of Waldencast by 15.1% in the 4th quarter. Barclays PLC now owns 37,342 shares of the company’s stock worth $150,000 after purchasing an additional 4,906 shares during the period. Finally, Rhumbline Advisers lifted its stake in shares of Waldencast by 15.2% in the 1st quarter. Rhumbline Advisers now owns 61,630 shares of the company’s stock worth $185,000 after purchasing an additional 8,151 shares during the period. Institutional investors own 41.97% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. Wall Street Zen cut shares of Waldencast from a “hold” rating to a “sell” rating in a research note on Thursday, May 22nd. Canaccord Genuity Group lowered their price objective on shares of Waldencast from $6.00 to $5.00 and set a “buy” rating on the stock in a research note on Thursday, May 15th. Alliance Global Partners reiterated a “buy” rating on shares of Waldencast in a research note on Thursday, May 15th. Finally, Telsey Advisory Group lowered their price objective on shares of Waldencast from $4.00 to $3.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 20th. Five investment analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $4.97.

Waldencast Stock Up 11.9%

Waldencast stock opened at $1.78 on Monday. The firm has a 50 day moving average of $2.04 and a 200 day moving average of $2.48. Waldencast PLC has a 12-month low of $1.48 and a 12-month high of $4.40. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.35 and a quick ratio of 0.66.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.